EM SAQs · Pre-eclampsia and eclampsia (ED)
Severe pre-eclampsia and eclampsia — three pillars
ACEM-style SAQ on severe pre-eclampsia management: magnesium, BP control, delivery.
On this page
Study tools
Target exams
ACEMFRCEMABEM
Prompt
A 30-year-old primigravida at 36 weeks presents with BP 178/114, severe headache, visual scotomata and hyperreflexia. Proteinuria 3+. Outline diagnosis with severe features, immediate ED management including magnesium and antihypertensives with doses, monitoring for toxicity, and definitive therapy. (10 marks)
Model answer
Reveal model answerShowHide
Diagnosis: pre-eclampsia — new hypertension ≥140/90 after 20 weeks with proteinuria/end-organ features. Severe features present: BP ≥160/110, cerebral/visual symptoms, hyperreflexia.[10]
Three pillars (parallel):
- Magnesium sulphate seizure prophylaxis: 4 g IV over 20 minutes, then 1 g/h for 24 hours (including postpartum). Recurrent seizure: 2 g IV bolus. Monitor reflexes, respiratory rate and urine output; antidote calcium gluconate 10 mL of 10% IV. Magpie supports prophylaxis; Collaborative Eclampsia Trial supports treatment superiority over diazepam/phenytoin.[2][3][9][15]
- BP control toward ~140–150 / 90–100 (Adebayo acute-treatment target; avoid overshoot): labetalol 20 mg IV, then 40 mg then 80 mg every 20 minutes (cumulative maximum 300 mg; Vigil-De Gracia), or hydralazine 5 mg IV every 20 minutes up to five doses, or nifedipine 10 mg oral (Vermillion). Never ACEI/ARB (NICE NG133).
- Delivery is the only cure — urgent obstetric involvement; continuous CTG; left lateral tilt; NICE NG133 limits maintenance fluids to 80 mL/hour in severe pre-eclampsia unless there are other ongoing losses.[20][12]
Labs: FBC (platelets), LFT, U&E, coag, urine PCR; watch for HELLP.[11]
References8ShowHide
- [2]Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial. Lancet, 2002.PMID 12057549
- [3]Eclampsia Trial Collaborative Group Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet, 1995.PMID 7769899
- [10]Leeman L, Dresang LT, Fontaine P Hypertensive disorders of pregnancy Am Fam Physician, 2016.PMID 26926408
- [9]Lu JF, Nightingale CH Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles Clin Pharmacokinet, 2000.PMID 10803454
- [15]Abdul MA, Nasir UI, Khan N, Yusuf MD Low-dose magnesium sulphate in the control of eclamptic fits: a randomized controlled trial Arch Gynecol Obstet, 2013.PMID 22930148
- [12]Vigil-De Gracia P, Lasso M, Ruiz E, et al. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial Eur J Obstet Gynecol Reprod Biol, 2006.PMID 16621226
- [20]National Institute for Health and Care Excellence Hypertension in pregnancy: diagnosis and management NICE guideline NG133, 2019.Source
- [11]Haram K, Svendsen E, Abildgaard U The HELLP syndrome: clinical issues and management. A review BMC Pregnancy Childbirth, 2009.PMID 19245695